4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0001127602-15-022957
CIK 0000884731operating
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:22 PM ET
Size
11.1 KB
Accession
0001127602-15-022957
Insider Transaction Report
Form 4
BERGER HARVEY J M D
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Performance stock unit
2015-07-15−36,800→ 0 total→ Common Stock (36,800 underlying) - Exercise/Conversion
Common Stock
2015-07-15+36,800→ 1,383,862 total - Tax Payment
Common Stock
2015-07-15$8.35/sh−17,370$145,040→ 1,366,492 total
Holdings
- 245,251(indirect: By Spouse)
Common Stock
- 246,054(indirect: Daughter)
Common Stock
- 248,745(indirect: Daughter)
Common Stock
- 1,864,286(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
- [F2]Represents shares withheld to satisfy witholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
- [F3]The reporting person is a managing member of this LLC.
- [F4]Each performance stock unit represents a right to receive one share of ARIAD common stock.
- [F5]The performance stock units vested on 7/15/15.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:22 PM ET
- Size
- 11.1 KB